{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaobqnsyicoh6bi6xtdsrk6cw2j5qekhql2i6qfflbhtinllmnvq4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mloxeseoihz2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidizv76ofys7maay4r35sfwvgornwajpzy43jz3tltit5mkumc6oi"
    },
    "mimeType": "image/jpeg",
    "size": 181096
  },
  "path": "/news/2026-05-drug-memory-decision-issues-affecting.html",
  "publishedAt": "2026-05-12T18:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Schizophrenia is a serious brain disorder that causes confused thinking, severe memory problems, and hallucinations. It affects about 23 million people worldwide, with cognitive dysfunction present in over 80% of patients. A research group led by scientists from Nagoya University in Japan has tested a drug used to treat an immune disease to see if it could reduce schizophrenia-related symptoms in mice.",
  "title": "Existing drug shows promise for memory and decision-making issues affecting most schizophrenia patients"
}